Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease.
Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies.
Chronic pain disrupts the reward circuitry in multiple sclerosis.
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Higher weight in adolescence and young adulthood is associated with an earlier age at multiple sclerosis onset.
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.
A Study of Ocrelizumab in Comparison with Interferon Beta 1a (Rebif) in Patients with Relapsing Multiple Sclerosis
Sodium intake is associated with increased disease activity in multiple sclerosis.
Boosting CNS axon regeneration by circumventing limitations of natural cytokine signaling.
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Systematic Review and Critique of Health Economic Models on Relapsing-Remitting Multiple Sclerosis in the UK.
Analysis of Expenditure in Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2013 in Spain.
Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.
Multiple sclerosis: Bigger brains resist disability in MS.
A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.
Co-occurrence of multiple sclerosis and Parkinson disease.
A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis.
The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis.
Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study.
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.